s.bergstrom

TL2 · Split

Contributes reviews on supplier material. Based in Split.

Joined 7 March 2025 · last posted 5d · groups: regional-apac

62 posts, newest first. Showing up to 150.

How shortages have affected compounding permissions — does this still hold? Replied, post #30 · Access › Shortages · 23 Jul 2026 · 3 likes Adding the boring version of shortages, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
Irish differences from the UK position — what changed since Replied, post #8 · Regional › UK & Ireland · 22 Jul 2026 · 3 likes The arithmetic in post #7 is right; the assumption feeding it is the part to check. Anyone quoting an eligibility threshold should say which document it comes from. The…
Priming a pen and whether the primed volume is wasted Replied, post #13 · Devices › Pens & autoinjectors · 19 Jul 2026 · 0 likes Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated, for a limited time (often 28 days). Check your specific…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #52 · Start Here › Welcome · 17 Jul 2026 · 0 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #4 · Compounds › Repair & healing peptides · 10 Jul 2026 · 0 likes Confirming post #3 from a second method, which matters more than confirming it from a second person. Publication patterns in the BPC-157 literature: a large proportion…
Immortal time bias in a claims-database study — one year on Replied, post #11 · Evidence › Study critique · 7 Jul 2026 · 0 likes Defending a design that is being criticised unfairly is as useful as criticising one that deserves it, and it happens far less often.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #26 · Analytics › Home & field testing · 25 Jun 2026 · 0 likes Marking my uncertainty on consumer-accessible tests explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
An appeal that succeeded, with the letter structure — the long version Replied, post #60 · Access › Insurance & coverage · 6 Jun 2026 · 28 likes Where I part company with post #59, and it is a narrow parting. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #88 · Sourcing › Red flags · 6 Jun 2026 · 0 likes For anyone finding this later: the short answer on certificate whose chromatogram axes is that it depends on one thing, and the rest of the thread is people identifying…
Bariatric surgery history: altered anatomy, altered expectations Replied, post #30 · Clinical › Special populations · 29 May 2026 · 0 likes Post #28 describes the usual case. This is about the unusual one. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings…
Follow-up: Sleep quality changes during weight loss Replied, post #31 · Wellbeing › Sleep · 27 May 2026 · 8 likes Good question, well framed, and I would like to see it answered properly.
Why cagrilintide alone is discussed so much less than in combination — does this still… Started this topic · Compounds › Cagrilintide & amylin analogues · 24 May 2026 · 40 likes Why cagrilintide alone is discussed so much less than in combination — does this still hold? — that is the question, and I have not found it answered plainly anywhere I…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #7 · Sourcing › Independent verification · 26 Apr 2026 · 3 likes Taking post #6 at face value and following it one step further. Where an independent figure and a declared figure differ by less than method repeatability, that is…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #83 · Compounds › Tirzepatide · 15 Apr 2026 · 20 likes I had written a reply contradicting post #79 and deleted it. Here is what survived. SURMOUNT-4's randomised withdrawal design is the strongest available evidence about…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #35 · Sourcing › Logistics · 6 Apr 2026 · 6 likes The failure mode on Regional warehouse stock versus direct is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it…
Blinding yourself: practical methods and their limits Replied, post #14 · Research Methods › N-of-1 designs · 29 Mar 2026 · 21 likes On blinding yourself the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #5 · Practice › Reconstitution · 28 Mar 2026 · 6 likes Summarising the Swirling versus inverting versus leaving thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #18 · Sourcing › Red flags · 18 Mar 2026 · 17 likes Checked the supplier claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
Preprint servers and what screening they do Replied, post #86 · Evidence › Preprints · 12 Mar 2026 · 6 likes A preprint reporting a null result is more likely to stay a preprint, which biases the published literature and makes preprint servers more valuable rather than less.
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #74 · Compounds › Semaglutide · 4 Mar 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #79 · Practice › Dosing & titration · 19 Feb 2026 · 2 likes Post #76 is right about the mechanism and I think understates the practical bit. Holding at a dose that is working is a legitimate position and it is not what the trial…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #74 · Clinical › Bloodwork · 12 Feb 2026 · 27 likes Reading rather than answering, but this is the post I would point somebody at.
Amylin receptor signalling and satiety — what changed since Replied, post #23 · Pharmacology › Receptor biology · 30 Jan 2026 · 30 likes Agreed on all of that, and I have nothing to add to it.
Request: export my own posts — one year on Replied, post #40 · Meta › Feature requests · 29 Jan 2026 · 3 likes Request that would help newcomers more than regulars: show the subcategory description on hover in the category list. The names are terse and the descriptions are good.
Designing a personal experiment that could change your mind — one year on Replied, post #6 · Research Methods › N-of-1 designs · 29 Jan 2026 · 28 likes Picking up post #3: that is the part I would want checked first. Record everything that changed, not just the intervention. Personal experiments are confounded by life,…
MHRA statements, read directly Replied, post #74 · Regional › UK & Ireland · 23 Jan 2026 · 3 likes The relevant national body publishes its decisions and its shortage notifications directly, and those are the primary sources rather than any secondary summary. Happy…
Personal import allowances, compared — a second dataset Replied, post #54 · Access › International · 19 Jan 2026 · 0 likes Personal import allowances has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
What a purity-only report leaves out Replied, post #104 · Sourcing › Independent verification · 26 Nov 2025 · 1 like A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. If the premise is wrong, everything after…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #52 · Practice › Interactions · 18 Nov 2025 · 21 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #5 · Safety › Contraindications · 14 Nov 2025 · 11 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. Adding it in case it saves somebody…
The anatomy of a question that gets answered within an hour — the long version Replied, post #29 · Start Here › How to Ask · 26 Oct 2025 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. The answer changed when I changed how…
Amylin receptor signalling and satiety Replied, post #11 · Pharmacology › Receptor biology · 25 Oct 2025 · 6 likes Building on post #9 rather than restating it. Where a mechanism is proposed to explain an effect, the useful follow-up is what observation would distinguish it from the…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #112 · Analytics › HPLC & UHPLC · 18 Oct 2025 · 7 likes Post #110 describes the usual case. This is about the unusual one. Something worth flagging about Resolution and tailing factor: the strongest-sounding claims in this…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #23 · Devices › Pens & autoinjectors · 14 Oct 2025 · 17 likes Holding the pen in place for the stated count after the plunger stops is the manufacturer's answer to leakage at the site. It is on the instruction leaflet and it is…
Documentation that materially improves an appeal's chances Replied, post #20 · Access › Insurance & coverage · 6 Oct 2025 · 8 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. Noting that I have skin in this…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #57 · Practice › Reconstitution · 18 Sep 2025 · 0 likes I would put moderate confidence on the mainstream reading of Over-dilution and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #121 · Access › Insurance & coverage · 15 Sep 2025 · 0 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #58 · Compounds › Semaglutide · 14 Sep 2025 · 15 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
Why oral semaglutide needs an absorption enhancer at all Replied, post #29 · Compounds › Oral incretins · 29 Aug 2025 · 32 likes Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and analysed. Comparing it to oral semaglutide as…
Repeatability versus intermediate precision Replied, post #34 · Analytics › Method validation · 21 Jun 2025 · 0 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one.
Regional warehouse stock versus direct despatch Replied, post #2 · Sourcing › Logistics · 29 May 2025 · 10 likes Regional stock shortens the exposure window more than any packing improvement and is the practical argument for it beyond speed. I would be glad to be shown a cleaner…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #45 · Compounds › Cagrilintide & amylin analogues · 21 May 2025 · 6 likes The arithmetic in post #44 is right; the assumption feeding it is the part to check. Amylin analogues affect gastric emptying as well, so the mechanism overlaps the…
Vagal afferents and the gut-brain pathway Replied, post #4 · Pharmacology › Receptor biology · 15 May 2025 · 5 likes Signalling through cyclic AMP is the canonical pathway and is not the only one. Beta-arrestin recruitment differs between ligands and its clinical significance here is…
A claim built entirely on a subgroup analysis Replied, post #22 · Evidence › Study critique · 7 May 2025 · 7 likes Narrowing post #21, because the general version has more than one answer. I keep a log for claim built specifically because my memory of it turned out to be…
Holding a dose indefinitely: is there a documented downside? Replied, post #20 · Practice › Dosing & titration · 5 May 2025 · 17 likes Post #17 answers the question as asked. The question underneath it is different. Source for the holding a dose figure, since it was asked for. It is in the discussion…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #96 · Compounds › Cagrilintide & amylin analogues · 11 Apr 2025 · 0 likes Amylin analogue mechanism: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #30 · Sourcing › Vendor reports · 28 Mar 2025 · 9 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable.
Cost per milligram, computed honestly across formats — the long version Replied, post #38 · Access › Pricing · 19 Mar 2025 · 0 likes Cost per week at a maintenance dose is the figure most people actually want and least often calculate. A single observation, in a thread that deserves better than…
Maintainer handover: how it works Replied, post #72 · Meta › Wiki maintenance · 18 Mar 2025 · 14 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #44 · Practice › Reconstitution · 1 Mar 2025 · 18 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
Ipamorelin selectivity claims and where they came from Replied, post #14 · Compounds › Secretagogues & GH axis · 18 Feb 2025 · 4 likes A methods point on ipamorelin selectivity claims rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
Feature request: should a dose-equivalence tool exist at all? Replied, post #22 · Data & Tools › Calculators · 31 Jan 2025 · 3 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
Reading an MS report that only gives you a single number Replied, post #2 · Analytics › Mass spectrometry · 27 Jan 2025 · 11 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
Distinguishing a deletion sequence by mass alone Replied, post #9 · Analytics › Mass spectrometry · 22 Jan 2025 · 5 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #89 · Compounds › Semaglutide · 21 Jan 2025 · 30 likes This follows post #88 rather than contradicting it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters.…
Follow-up: Individual participant data versus aggregate data Replied, post #81 · Evidence › Meta-analyses · 11 Jan 2025 · 0 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
Why "any advice?" is the least effective ending for a post Replied, post #34 · Start Here › How to Ask · 14 Nov 2024 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
Second pass at: Reimbursement variation across member states Replied, post #5 · Regional › European Union · 31 Aug 2024 · 0 likes Bookmarking this. I will come back when I have something worth adding.
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #11 · Practice › Administration · 7 Aug 2024 · 24 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
Guidelines revision: what changed and why Replied, post #30 · Meta › Announcements · 25 Jul 2024 · 26 likes Taking post #29 at face value and following it one step further. My understanding of guidelines revision is a few years old and may have been superseded. If it has…
Blind submission and why it changes minds Replied, post #15 · Sourcing › Independent verification · 15 Jul 2024 · 0 likes Post #12 is the version of this I will quote in future. One addition. On blind submission: the maintained page in the documentation commons covers the general case with…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #74 · Practice › Dosing & titration · 8 Jul 2024 · 0 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…